Leverage Shares - 3x Palantir
PLT3.L
London Stock Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Leverage Shares Public Limited Company (Leverage Shares PLC) issues the Leverage Shares 3x Palantir ETP Securities (ticker: PLT3.L), a collateralized exchange-traded product (ETP) that seeks to deliver three times (3x) the daily performance of Palantir Technologies Inc. (PLTR) stock, net of fees and expenses, by tracking the iSTOXX Leveraged 3x PLTR Index; this physically replicated debt security offers leveraged long exposure to the underlying equity for professional investors, with accumulating dividend treatment and a total expense ratio of 0.75% per annum. The ETP, with ISIN XS2663694680, trades primarily in USD on the London Stock Exchange and is available across multiple European venues including Borsa Italiana, Euronext Paris, Euronext Amsterdam, and others in countries such as the United Kingdom, Italy, Germany, France, Spain, Netherlands, Ireland, Poland, and Belgium. Leverage Shares PLC, founded in 2017 and headquartered at 2nd Floor, Block 5, Irish Life Centre, Abbey Street Lower, Dublin 1, D01 P767, Ireland, with additional offices including in Greenwich, Connecticut, serves as the issuer and specializes in a broad portfolio of over 180 single-stock ETPs providing leveraged (5x, 3x, 2x), inverse (-1x, -2x, -3x, -5x), and delta-one (1x) exposures to leading global stocks, ETFs, custom indices, and exchange-traded commodities (ETCs), all physically backed and listed on major European exchanges. In September 2025, Leverage Shares launched 19 new ETPs on the London Stock Exchange, marking the first-ever 3x leveraged products on stocks including Robinhood (HOOD), Hims & Hers (HIMS), and UnitedHealth (UNH), alongside leveraged and inverse exposures to Intel, Broadcom, ASML, and others, amid record-breaking trading volumes with year-to-date turnover through August 2025 up 86% versus 2024 and average monthly trading up nearly 50% year-over-year. The company, managing approximately $1.5 billion in assets under management as of September 2025, continues to expand its offerings with plans for further growth in income and derivative-based ETPs into 2025, reinforcing its position as Europe's pioneer and largest issuer of single-stock ETPs while enabling white-label solutions for third-party asset managers.